Is Malondialdehyde an Acceptable Biomarker of Oxidative Stress In Children with Down Syndrome?

authors:

avatar Abolghasem Jouyban 1 , avatar Maryam Khoubnasabjafari 2 , *

Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, IR Iran
Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran

how to cite: Jouyban A, Khoubnasabjafari M. Is Malondialdehyde an Acceptable Biomarker of Oxidative Stress In Children with Down Syndrome?. Iran J Pediatr. 2017;27(5):e6892. https://doi.org/10.5812/ijp.6892.

References

  • 1.

    He J, Li T, Chen J, Liu Y, Xiong F, Yang J, et al. Plasma antioxidant enzymes and lipoperoxidation status in children with Down syndrome. Clin Biochem. 2016;49(1-2):61-5. [PubMed ID: 26340803]. https://doi.org/10.1016/j.clinbiochem.2015.08.026.

  • 2.

    Muchova J, Sustrova M, Garaiova I, Liptakova A, Blazicek P, Kvasnicka P, et al. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol Med. 2001;31(4):499-508. [PubMed ID: 11498283].

  • 3.

    Capone G, Kim P, Jovanovich S, Payne L, Freund L, Welch K, et al. Evidence for increased mitochondrial superoxide production in Down syndrome. Life Sci. 2002;70(24):2885-95. [PubMed ID: 12269400].

  • 4.

    Gromadzinska J, Wasowicz W, Sklodowska M, Strozynski H. Glutathione peroxidase activity, lipid peroxides and selenium status in blood in patients with Down's syndrome. J Clin Chem Clin Biochem. 1988;26(5):255-8. [PubMed ID: 2969937].

  • 5.

    Mehar Sulthana S, Nandha Kumar S, Sridhar MG, Vishnu Bhat B, Ramachandra Rao K. Oxidative stress in children with Down syndrome. Curr Pediatr. Res. 2012;16(2):111-4.

  • 6.

    Casado A, Lopez-Fernandez ME, Ruiz R. Lipid peroxidation in Down syndrome caused by regular trisomy 21, trisomy 21 by Robertsonian translocation and mosaic trisomy 21. Clin Chem Lab Med. 2007;45(1):59-62. [PubMed ID: 17243916]. https://doi.org/10.1515/CCLM.2007.011.

  • 7.

    Garaiova I, Muchova J, Sustrova M, Blazicek P, Sivonova M, Kvasnicka P, et al. The relationship between antioxidant systems and some markers of oxidative stress in persons with Down syndrome. Biologia. 2004;59(6):787-94.

  • 8.

    Khoubnasabjafari M, Ansarin K, Jouyban A. Critical review of malondialdehyde analysis in biological samples. Curr Pharm Analysis. 2016;12(1):4-17.

  • 9.

    Gil P, Farinas F, Casado A, Lopez-Fernandez E. Malondialdehyde: a possible marker of ageing. Gerontology. 2002;48(4):209-14. [PubMed ID: 12053109].

  • 10.

    Inal ME, Kanbak G, Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta. 2001;305(1-2):75-80. [PubMed ID: 11249925].

  • 11.

    Inal ME, Sunal E, Kanbak G, Zeytinoglu S. Effects of postmenopausal hormone replacement and alpha-tocopherol on the lipid profiles and antioxidant status. Clin Chim Acta. 1997;268(1-2):21-9. [PubMed ID: 9495568].